Suppr超能文献

提取物对亚硒酸钠诱导实验动物模型白内障形成的预防作用。

The Preventive Effects of Extract on Sodium Selenite-Induced Cataractogenesis in Experimental Animal Models.

作者信息

Azadbakht Momammad, Asghari Mohammad, Nowroozpoor Dailami Kiumars, Davoodi Ali, Ahmadi Amirhossein

机构信息

Department of Pharmacognosy and Biotechnology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Evid Based Complement Alternat Med. 2020 Nov 23;2020:3708730. doi: 10.1155/2020/3708730. eCollection 2020.

Abstract

MATERIALS AND METHODS

Neonatal rats received a single dose of sodium selenite as an intraperitoneal injection (30 mol/kg) on day 10 postnatal to induce cataract. Animals were then posttreated with various oral solutions of extract at 200 mg/kg or 400 mg/kg once daily on days 10-16 postnatal. Cataract was evaluated by slit-lamp, and lens opacification was analyzed in each group 24 hours after the last treatment at day seven postadministration of the extracts or vehicle. The total protein concentration of lenses, glutathione reductase activity as the glutathione antioxidant capacity, and malondialdehyde content as a marker of lipid peroxidation were further assessed in removed rat lenses on day 30 postnatal.

RESULTS

All lenses in the healthy and control plant groups were clear. Sodium selenite significantly increased cataract grade (2.8 ± 0.2) when compared to the healthy group ( = 0.001). However, cataract grades were decreased considerably as 1.9 ± 0.72 and 1.5 ± 0.85 in groups that received 200 mg/kg and 400 mg/kg oral extract of , respectively. extract also restored all abnormalities of biochemical markers induced by sodium selenite.

CONCLUSION

Our data suggest that could be a promising candidate as a safe alternative treatment in cataracts upon further clinical trials. This effect is probably associated with the antioxidant activity of .

摘要

材料与方法

新生大鼠在出生后第10天腹腔注射一次亚硒酸钠(30 μmol/kg)以诱导白内障形成。然后在出生后第10 - 16天,动物每天接受一次200 mg/kg或400 mg/kg的各种提取物口服溶液进行后续治疗。通过裂隙灯评估白内障情况,并在提取物或赋形剂给药后第7天最后一次治疗后24小时分析每组的晶状体混浊情况。在出生后第30天对摘除的大鼠晶状体进一步评估晶状体总蛋白浓度、作为谷胱甘肽抗氧化能力指标的谷胱甘肽还原酶活性以及作为脂质过氧化标志物的丙二醛含量。

结果

健康组和对照植物组的所有晶状体均清晰。与健康组相比,亚硒酸钠显著增加了白内障等级(2.8 ± 0.2)(P = 0.001)。然而,分别接受200 mg/kg和400 mg/kg提取物口服的组中,白内障等级显著降低,分别为1.9 ± 0.72和1.5 ± 0.85。提取物还恢复了由亚硒酸钠诱导的所有生化标志物异常。

结论

我们的数据表明,在进一步的临床试验后,[提取物名称]可能是一种有前景的安全替代治疗白内障的候选药物。这种作用可能与[提取物名称]的抗氧化活性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467c/7704146/a9d931b0f978/ECAM2020-3708730.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验